saredutant (SR48968)

DRUG3 trials

Sponsors

Sanofi

Conditions

Depressive DisorderDepressive Disorder, MajorMajor Depressive Disorder

Phase 3

An Eight-week Study Evaluating the Efficacy of a 100mg Dose of Saredutant Once Daily, in Elderly Patients With Major Depressive Disorder

CompletedNCT00415142

SanofiDepressive Disorder

Start: 2006-12-31End: 2008-02-29Updated: 2016-05-24

An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder

CompletedNCT00531622

SanofiMajor Depressive Disorder

Start: 2007-09-30End: 2009-01-31Updated: 2016-05-24

An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder

CompletedNCT00629551

SanofiDepressive Disorder, Major

Start: 2008-02-29End: 2009-02-28Updated: 2016-05-26